LIVE

MarketsMicron suspends work on $4.5B Taiwan plant amid labor dispute: Bloomberg MarketsSouth Korea seeks 4th crypto tax delay, targets 2029 start BusinessCitizens raises Progyny stock price target on guidance increase MarketsCircle’s $182M ARC Token Sale Drives Q3 Growth While USDC Onchain Volume Hits $13.9T MarketsTenaris posts Q3 revenue beat on North American demand growth; shares up 3%MarketsWhy Major US Companies Are Pushing Back Against Stock Tokenization: MEXC CEO TechRoyal London plans IT outsourcing shake-up as staff brace for redundancies WorldUS sanctions trio over alleged Iran air defense scheme - Yeni Şafak English BusinessGoldman Sachs lowers Timken stock price target to $126 on valuation BusinessCitizens raises Procore stock price target to $91 on strong results BusinessRaymond James raises e.l.f. Beauty stock price target on strong results BusinessCitizens raises Precigen stock price target to $12 on strong sales BusinessCitizens cuts NICE Systems stock price target on slowing growth MarketsWhy is Morgan Advanced Materials stock surging today?BusinessBorussia Dortmund and SPORTFIVE extend their partnership until 2034 MarketsWhy is Nemetschek stock sliding today?MarketsWhy is Bouygues stock rallying today?MarketsWhy is Air France KLM stock surging today?TechSony is selling more PS5 games but still struggling to meet console demand MarketsMicron pauses work on $4.5 billion Taiwan plant, Bloomberg News reports BusinessSES Delivers Solid 9 Months & Q3 2026 Results and Reiterates Full-Year Outlook BusinessWe Need To Talk More About Air Conditioning And its Energy Use LocalStock futures mixed day after midterm election rally MarketsRovi shares rise 8% after raising 2026 revenue outlook MarketsCanadian Natural Resources reports higher Q3 profit, maintains 2026 production outlookTRENDING TICKERS: $CRWD $FLNC $ASTS $VEEV $NTAP $EL $APP $LINC $NIQ $BETR $CCB $EG $GIL $IQMX $DAVA $QFIN $NOW $BULL $TMUS $HIMS $ROK $DOCS $TYGO $BIDU $MSTR $YRD $CURA $FCEL $YFOR $RHIMarketsMicron suspends work on $4.5B Taiwan plant amid labor dispute: Bloomberg MarketsSouth Korea seeks 4th crypto tax delay, targets 2029 start BusinessCitizens raises Progyny stock price target on guidance increase MarketsCircle’s $182M ARC Token Sale Drives Q3 Growth While USDC Onchain Volume Hits $13.9T MarketsTenaris posts Q3 revenue beat on North American demand growth; shares up 3%MarketsWhy Major US Companies Are Pushing Back Against Stock Tokenization: MEXC CEO TechRoyal London plans IT outsourcing shake-up as staff brace for redundancies WorldUS sanctions trio over alleged Iran air defense scheme - Yeni Şafak English BusinessGoldman Sachs lowers Timken stock price target to $126 on valuation BusinessCitizens raises Procore stock price target to $91 on strong results BusinessRaymond James raises e.l.f. Beauty stock price target on strong results BusinessCitizens raises Precigen stock price target to $12 on strong sales BusinessCitizens cuts NICE Systems stock price target on slowing growth MarketsWhy is Morgan Advanced Materials stock surging today?BusinessBorussia Dortmund and SPORTFIVE extend their partnership until 2034 MarketsWhy is Nemetschek stock sliding today?MarketsWhy is Bouygues stock rallying today?MarketsWhy is Air France KLM stock surging today?TechSony is selling more PS5 games but still struggling to meet console demand MarketsMicron pauses work on $4.5 billion Taiwan plant, Bloomberg News reports BusinessSES Delivers Solid 9 Months & Q3 2026 Results and Reiterates Full-Year Outlook BusinessWe Need To Talk More About Air Conditioning And its Energy Use LocalStock futures mixed day after midterm election rally MarketsRovi shares rise 8% after raising 2026 revenue outlook MarketsCanadian Natural Resources reports higher Q3 profit, maintains 2026 production outlookTRENDING TICKERS: $CRWD $FLNC $ASTS $VEEV $NTAP $EL $APP $LINC $NIQ $BETR $CCB $EG $GIL $IQMX $DAVA $QFIN $NOW $BULL $TMUS $HIMS $ROK $DOCS $TYGO $BIDU $MSTR $YRD $CURA $FCEL $YFOR $RHI

Skip to content

El Grupo Menarini y Ryvu Therapeutics presentan los primeros datos del estudio JASPIS-01 sobre dapolsertib

Source: PR Newswire M&A · Nov 05, 2026 08:49 UTC

The Quick Take

El Grupo Menarini y Ryvu Therapeutics presentan, en la reunión anual de la ASH de 2026, los primeros datos clínicos del estudio de fase II JASPIS-01 sobre el dapolsertib (MEN1703, SEL24) en pacientes con linfoma no Hodgkin de células B agresivo, en recaída o refractario, que han recibido...

Read the full story at PR Newswire M&A →

Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.

Related

Citizens raises Progyny stock price target on guidance increase

All News · 14m ago

Goldman Sachs lowers Timken stock price target to $126 on valuation

All News · 20m ago

Citizens raises Procore stock price target to $91 on strong results

All News · 20m ago

Raymond James raises e.l.f. Beauty stock price target on strong results

All News · 20m ago